<p>A) Cell cycle analysis by propidium iodide DNA labeling flow cytometry of ULTI cells pretreated with pifithrin-α (PFTa) or DMSO vehicle, then treated with etoposide (ETOP) or DMSO vehicle under non-permissive conditions with 0.5% FBS. B) Quantitation of cell cycle phase of ULTI cells pretreated with pifithrin-α (PFTa) or DMSO vehicle, then treated with etoposide (ETOP) or DMSO vehicle under non-permissive conditions with 0.5% FBS. Dark grey bars indicate percent of cells in G0/G1, white bars indicate percent of cells in S phase, and light grey bars indicate percent of cells in G2/M phase. Error bars represent standard error of the mean.</p
<p>(<b>A</b>) D283-MED cells were treated with [20 µM] etoposide for indicated times and the p53 pro...
<p>(A) MSC were treated on day 0 for 24 h with 0.75 μM etoposide. On day 1, 3 and upon reconstitutio...
<p>(left) 293T cells were treated with CTRL or GEN1 siRNA for 48 h stained with propidium iodine (PI...
<p>A) Western blot of whole cell lysates from NIH 3T3 fibroblasts or ULTI cells under both permissiv...
<p>A) Crystal violet proliferation assay, in which absorbances were normalized to that of 10% FBS to...
<p>A. HCT116 wild-type (wt), B. HCT116 <i>p53</i><sup>−/−</sup> and C. HCT116 <i>p21</i><sup>−/−</su...
<p>(<b>A–C</b>) D283-MED cells were co-transfected with p53-dsRedXP and MDM2-YFP and imaged using ti...
<p>(<b>A</b>) Cell cycle analyses of wt HCT116 cells, HCT116 cells stably expressing U19, and HCT116...
<p>(<b>A</b>) Inhibition of p53 expression in p53siRNA U2-OS. Actin was used as loading control. (<b...
<p>MCF7 (<b>A</b>), MDA-MB-231 (<b>B</b>), and Panc-1 (<b>C</b>) cells were plated at 20% confluence...
<p>DNA damage in cells occurs from both endogenous and exogenous sources, and failure to repair such...
<p>A. Top panel: Western analysis of lysates from CSF1R overexpressing (CSF1R) or Vector alone (Vect...
<p>HCT116 and p53KO cells were incubated in 15 μM IGG, 30 μM IGG or vehicle control for either 8 or ...
<p>Percentage of cells in each cell cycle phase by flow cytometry for knockdown of NET4/TMEM53 and c...
<p>(A) The cell cycle phases of DBP5, GLE1 and IPPK knocked-down cells were investigated by flow cyt...
<p>(<b>A</b>) D283-MED cells were treated with [20 µM] etoposide for indicated times and the p53 pro...
<p>(A) MSC were treated on day 0 for 24 h with 0.75 μM etoposide. On day 1, 3 and upon reconstitutio...
<p>(left) 293T cells were treated with CTRL or GEN1 siRNA for 48 h stained with propidium iodine (PI...
<p>A) Western blot of whole cell lysates from NIH 3T3 fibroblasts or ULTI cells under both permissiv...
<p>A) Crystal violet proliferation assay, in which absorbances were normalized to that of 10% FBS to...
<p>A. HCT116 wild-type (wt), B. HCT116 <i>p53</i><sup>−/−</sup> and C. HCT116 <i>p21</i><sup>−/−</su...
<p>(<b>A–C</b>) D283-MED cells were co-transfected with p53-dsRedXP and MDM2-YFP and imaged using ti...
<p>(<b>A</b>) Cell cycle analyses of wt HCT116 cells, HCT116 cells stably expressing U19, and HCT116...
<p>(<b>A</b>) Inhibition of p53 expression in p53siRNA U2-OS. Actin was used as loading control. (<b...
<p>MCF7 (<b>A</b>), MDA-MB-231 (<b>B</b>), and Panc-1 (<b>C</b>) cells were plated at 20% confluence...
<p>DNA damage in cells occurs from both endogenous and exogenous sources, and failure to repair such...
<p>A. Top panel: Western analysis of lysates from CSF1R overexpressing (CSF1R) or Vector alone (Vect...
<p>HCT116 and p53KO cells were incubated in 15 μM IGG, 30 μM IGG or vehicle control for either 8 or ...
<p>Percentage of cells in each cell cycle phase by flow cytometry for knockdown of NET4/TMEM53 and c...
<p>(A) The cell cycle phases of DBP5, GLE1 and IPPK knocked-down cells were investigated by flow cyt...
<p>(<b>A</b>) D283-MED cells were treated with [20 µM] etoposide for indicated times and the p53 pro...
<p>(A) MSC were treated on day 0 for 24 h with 0.75 μM etoposide. On day 1, 3 and upon reconstitutio...
<p>(left) 293T cells were treated with CTRL or GEN1 siRNA for 48 h stained with propidium iodine (PI...